Researchers from the Netherlands Institute for Neuroscience (NIN), in collaboration with the University of Münster (Germany) and the University of Turku (Finland), have discovered a novel biomarker for severe multiple sclerosis (MS). This research will contribute to our understanding of the molecular processes involved in progressive MS, and may aidContinuar Leyendo

Laura Goodman was close to finalizing a prototype of a new test that can detect any tick-borne disease. Unlike some current tests, it could provide results even before symptoms occur – and even for unknown diseases. New York, June 04, 2025.- That’s important, because ticks around the world can potentiallyContinuar Leyendo

New York, May 14, 2025.- Fanconi anemia is an aggressive, life-threatening disorder. Most individuals living with this rare genetic condition, characterized by bone marrow failure and cancer predisposition, survive into adulthood only with bone marrow transplantation and regular cancer screening. But a new study demonstrates that mutations in one particularContinuar Leyendo

By Patricia Waldron New York, May 14, 2025.- Telling the difference between benign and cancerous thyroid nodules before surgery is notoriously challenging, but a new study finds that a combination of artificial intelligence and data analysis techniques may yield surprisingly accurate cancer predictions. The proof-of-concept study was conducted by researchersContinuar Leyendo